256
Participants
Start Date
July 31, 2004
Study Completion Date
October 31, 2012
Schwartz Gynecologic Oncology, PLLC, Brightwaters
UPMC Cancer Center at Magee Womens Hospital, Pittsburgh
Abington Memorial Hospital, Abington
Lankenau Hospital, Mainline Health System, Wynnwood
University of Virginia Health System, Charlottesville
Cancer Centers of the Carolinas, Greenville
Southeastern Gynecologic Oncology Riverdale, Riverdale
Atlanta Medical Center, Atlanta
St. Vincents Medical Center, Jacksonville
The Florida Hospital, Orlando
Women's Cancer Associates, St. Petersburg
Florida Gynecologic Oncology, Fort Myers
Vanderbilt-Ingram Cancer Center, Nashville
ACORN - The West Clinic, Memphis
St. Elizabeth Medical Center, Edgewood
University of Toledo Medical Center, Toledo
University Hospital Case Medical Center, Cleveland
Cleveland Clinic, Cleveland
University of Cincinnati Medical Center Barrett Cancer Center, Cincinnati
St. Vincent Indianapolis Hospital, Indianapolis
University of Wisconsin, Madison, Madison
University of Minnesota, Minneapolis
Northwestern University/Prentice Women's Hospital, Chicago
Rush University, Chicago
Washington University, St Louis
Saint Louis University, St Louis
University of Oklahoma Health Sciences Center, Oklahoma City
UT Southwestern Medical Center, Dallas
The Methodist Hospital, Houston
Kaiser Permanente, Los Angeles
University of California, Irvine
Legacy Health System, Portland
Yale University Medical Center, New Haven
The Cooper Health System, Camden
Saint Barnabas Medical Center, West Orange
Women & Infants Hospital, Providence
Lead Sponsor
Precision Therapeutics
INDUSTRY